The week of March 20, UT Health Austin’s Bipolar Disorder Center within the Mulva Clinic for the Neurosciences successfully completed the first SAINT protocol in Texas, and join institutions like Stanford, Harvard and John Hopkins as the only few sites proving this groundbreaking intervention to treat depression.
The SAINT protocol received FDA Breakthrough Device Designation and Clearance last year. In its core, it uses a personalized target identified by the individual’s neuroimaging data to guide the fast-acting and high intensity TMS protocol using neuronavigation.
https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2022.10.10.40
